Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes – PR-USA.net (press release)
|
Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
PR-USA.net (press release) Immunogenicity-related events, including urticaria, were more common among Victoza-treated patients than among comparator-treated patients in clinical … and more » |